Showing results (281-290 of 867) with videos related to

Sort By:
Pageof 87
Thrombosis Research|December 14, 2002
In vitro comparison of the effect of heparin, enoxaparin and fondaparinux on tests of coagulationLori Ann Linkins, Jim A Julian, Janice Rischke, et al.
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Allosteric modulation of exosite 1 attenuates polyphosphate-catalyzed activation of factor XI by thrombinRuiqi Yin, Vishal Patel, Rida A Malik, et al.
Clinical & Experimental Metastasis|September 25, 2008
Inhibition of osteolytic bone metastasis by unfractionated heparinColin K Yee, Martin Butcher, Melec Zeadin, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 29, 2020
Evaluation of a fully automated von Willebrand factor assay panel for the diagnosis of von Willebrand diseaseFrancesca Stufano, Luciano Baronciani, Paolo Bucciarelli, et al.
Blood|June 16, 2017
Exploring the global landscape of genetic variation in coagulation factor XI deficiencyRosanna Asselta, Elvezia Maria Paraboschi, Valeria Rimoldi, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|February 21, 2024
Safety and efficacy of combined dual antiplatelet therapy and factor VIII prophylaxis in patients with haemophilia A after acute coronary syndromePasquale Agosti, Simona Maria Siboni, Alessandro Ciavarella, et al.
The Lancet. Haematology|November 5, 2025
Von Willebrand factor and von Willebrand disease in ageing: mechanisms, evolving phenotypes, and clinical implicationsOmid Seidizadeh, Ferdows Atiq, Nathan T Connell, et al.
Haematologica|May 4, 2006
Fibrinogen Mumbai: intracellular retention due to a novel G434D mutation in the Bbeta-chain geneLuca Monaldini, Rosanna Asselta, Stefano Duga, et al.
Haematologica|August 18, 2025
Genetic determinants of clinical variability in type 2 von Willebrand disease: bridging genotype and phenotypeOmid Seidizadeh, Alessandro Ciavarella, Luciano Baronciani, et al.
Pageof 87